Engineered biohybrid therapeutics. Various drug delivery systems for the delivery of chemotherapeutic agents including micro/nanoparticles have been designed and widely evaluated both in animal models and clinical trials. The advancement of nanotechnology has made nanoparticles a promising candidate for controlled active target delivery systems. We focus on developing bacterial microrobots that are biomanufactured by the integration of bacteria with abiotic systems leading to advanced levels of functionalization. We also use engineering approaches with synthetic biology to develop a novel engineered biohybrid therapeutics (EBT).

Redox-responsive hydrogels. The electrochemically reversible redox couple has attracted considerable attention, and a major application is dynamic redox switching of drug delivery systems. Due to the accompanying hydrophobic/hydrophilic, neutral/cationic and complexation/dissociation transitions, the on-demand release of loaded drugs can be achieved in response to external redox stimuli. Our approach is based on the synthesis of organometallic compound containing hydrogel. We study on the transition in oxidation state in the hydrogel can induce change of their properties like hydrophilicity.

Wearable bioelectronics. Our research is focused on overcoming the limits of conventional biosensing devices. We exploit science and engineering approaches to improve the application of biosensors. We aim to develop ultimate electroanalytical wearable biosensors that improve the analytical performance of biomedical devices, intimately integrate with living systems, and thus provide new strategies to understand human physiology for point-of-care diagnostics and smart wound dressings. We develop flexible and wearable electrodes produced by direct laser writing and label free impedimetric biosensor for detection of biomarkers.